Tm Bioscience
This article was originally published in The Gray Sheet
Executive Summary
Diagnostics firm signs a co-exclusive licensing agreement for German biotech firm Epidauros' patents on a biomarker related to the P450-CYP2D6 gene. The firm will pay a signing fee and royalties to Epidauros on its P450 Tag-It tests that include the biomarker. Roche Diagnostics is the only other firm with a license for this marker, which it uses in its AmpliChip CYP450 test, cleared in 2004...